Credit Suisse Ag Bio Xcel Therapeutics, Inc. Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $24,663 - $117,374	-9,905 Reduced 31.49%	21,551 $54,000
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $86,220 - $385,629	13,493 Added 75.12%	31,456 $209,000
Q1 2023 May 10, 2023	BUY	$17.7 - $33.24 $70,499 - $132,394	3,983 Added 28.49%	17,963 $335,000
Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $1,537 - $3,364	-150 Reduced 1.06%	13,980 $300,000
Q3 2022 Nov 10, 2022	BUY	$11.19 - $17.89 $995 - $1,592	89 Added 0.63%	14,130 $167,000
Q2 2022 Aug 12, 2022	SELL	$9.03 - $21.55 $4,144 - $9,891	-459 Reduced 3.17%	14,041 $185,000
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $13,890 - $21,140	926 Added 6.82%	14,500 $303,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $1,267 - $2,210	63 Added 0.47%	13,574 $276,000
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $25,461 - $34,208	1,068 Added 8.58%	13,511 $410,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $203 - $271	-7 Reduced 0.06%	12,443 $361,000
Q1 2021 May 14, 2021	SELL	$39.04 - $64.6 $1.42 Million - $2.35 Million	-36,301 Reduced 74.46%	12,450 $537,000
Q4 2020 Feb 12, 2021	SELL	$42.46 - $56.58 $451,307 - $601,388	-10,629 Reduced 17.9%	48,751 $2.25 Million
Q3 2020 Nov 13, 2020	BUY	$37.44 - $64.63 $426,741 - $736,652	11,398 Added 23.75%	59,380 $2.57 Million
Q2 2020 Aug 12, 2020	BUY	$17.62 - $58.71 $845,442 - $2.82 Million	47,982 New	47,982 $2.54 Million

8.63M

34.5K

59.4K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $59.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.